ABSTRACT
Abstract Sarcoidosis is a multisystem granulomatous disorder of unknown aetiology. Cutaneous involvement occurs in up to 30% of patients and skin findings are often the initial presenting symptom. The facial atrophic form of sarcoidosis without associated ulceration in adolescents has rarely been described in the literature. We report a case of 13-year-old male patient with a facial atrophic sarcoidosis who was successfully treated with the combination of prednisone and hydroxychloroquine.
Subject(s)
Humans , Male , Adolescent , Sarcoidosis/drug therapy , Prednisone/administration & dosage , Facial Dermatoses/drug therapy , Hydroxychloroquine/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Sarcoidosis/pathology , Biopsy , Treatment Outcome , Drug Therapy, Combination , Facial Dermatoses/pathology , Granuloma/pathology , Granuloma/drug therapyABSTRACT
<p><b>OBJECTIVES</b>To detect telomerase activity in patients with mycosis fungoides (MF) and to study the role of telomerase in the tumorigenesis of MF.</p><p><b>METHODS</b>The technique of PCR-ELISA was employed to detect telomerase activity in 35 patients with various stages of MF.</p><p><b>RESULTS</b>92.3% tumor stage of MF, 78.6% plaque stage of MF and 75.0% patch stage of MF had positive telomerase activity. The control samples had no telomerase activity. Telomerase activity in tumor stage of MF was significantly higher than that in plaque stage, while the latter was higher than that in patch stage. Telomerase activity was correlated with the stage of MF.</p><p><b>CONCLUSION</b>High level of telomerase activity frequently occurred in patients with MF, suggesting that telomerase might play an important role in the tumorigenesis of MF and is a useful marker for the diagnosis of MF possibly.</p>